Want to join the conversation?
$TDC posted improved earnings in 2Q16, helped by lower expenses compared to 2Q15. Net income was $64MM or $0.49 per diluted share compared to net loss of $265MM or $1.87 per diluted share in 2Q15. Total revenue was down 4% to $599MM from $623MM last year. Non-GAAP diluted EPS was $0.71 in the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?